Patent application number | Description | Published |
20080234315 | M3 Muscarinic Acetylcholine Receptor Antagonists - The present invention is directed to novel Muscarinic Acetylcholine receptor antagonists of Formula (I), pharmaceutical compositions and methods of using them. Compounds of Formula (I) are, inter alia, | 09-25-2008 |
20080269291 | Chemical Compounds - The invention is directed to novel indolecarboxamide derivatives. Specifically, the invention is directed to compounds according to formula (I): | 10-30-2008 |
20080275079 | M3 Muscarinic Acetylcholine Receptor Antagonists - Muscarinic Acetylcholine receptor antagonists and methods of using them are provided. | 11-06-2008 |
20090076061 | MUSCARINIC ACETYCHOLINE RECEPTOR ANTAGONISTS - Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided. | 03-19-2009 |
20090093451 | IL-8 Receptor Antagonists - This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). | 04-09-2009 |
20090093492 | IL-8 RECEPTOR ANTAGONISTS - This invention relates to novel compounds of Formula (I) to (VII), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). | 04-09-2009 |
20090170871 | IL-8 Receptor Antagonists - This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). | 07-02-2009 |
20090258858 | MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS - Muscarinic Acetylcholine receptor antagonists and methods of using them are provided. | 10-15-2009 |
20090281110 | Method of Treatment - This invention relates to the use of sulfonamide substituted diphenyl urea compounds to treat endometriosis. | 11-12-2009 |
20090298810 | IL-8 Receptor Antagonists - This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (II-8). | 12-03-2009 |
20100130468 | INDOLE CARBOXAMIDES AS IKK2 INHIBITORS - The invention is directed to novel indole carboxamide derivatives. Specifically, the invention is directed to compounds according to formula (I): | 05-27-2010 |
20100298387 | IL-8 Receptor Antagonists - This invention relates to novel compounds, compositions and combinations thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). | 11-25-2010 |
20110059937 | IL-8 RECEPTOR ANTAGONISTS - This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). | 03-10-2011 |
20110105563 | IL-8 RECEPTOR ANTAGONISTS - This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). | 05-05-2011 |
20120040958 | INDOLE CARBOXAMIDES AS IKK2 INHIBITORS - The invention is directed to novel indole carboxamide compounds. Specifically, the invention is directed to compounds according to formula (I): | 02-16-2012 |
20120142668 | CATHEPSIN C INHIBITORS - Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease. | 06-07-2012 |